Wells Fargo
IMVT icon

Wells Fargo’s Immunovant IMVT Stock Holding History

Wells Fargo’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.65M Buy
146,639
+113,417
+341% +$3.46M ﹤0.01% 2734
2026
Q1 		$825K Sell
33,222
-46,445
-58% -$1.2M ﹤0.01% 3847
2025
Q4 		$2.03M Buy
79,667
+34,730
+77% +$774K ﹤0.01% 3419
2025
Q3 		$724K Buy
44,937
+8,664
+24% +$140K ﹤0.01% 4039
2025
Q2 		$580K Buy
36,273
+7,480
+26% +$113K ﹤0.01% 4032
2025
Q1 		$492K Buy
28,793
+730
+3% +$15.3K ﹤0.01% 4109
2024
Q4 		$695K Buy
28,063
+9,349
+50% +$265K ﹤0.01% 3959
2024
Q3 		$534K Sell
18,714
-773
-4% -$22.8K ﹤0.01% 3953
2024
Q2 		$514K Buy
19,487
+1,825
+10% +$51.9K ﹤0.01% 3893
2024
Q1 		$571K Buy
17,662
+1,191
+7% +$43.5K ﹤0.01% 3802
2023
Q4 		$694K Sell
16,471
-50,543
-75% -$1.86M ﹤0.01% 3656
2023
Q3 		$2.57M Sell
67,014
-258
-0.4% -$5.83K ﹤0.01% 2610
2023
Q2 		$1.28M Buy
67,272
+3,995
+6% +$74.5K ﹤0.01% 3279
2023
Q1 		$981K Buy
+63,277
New +$1.1M ﹤0.01% 3393
2022
Q4 		– Sell
-123
Closed -$1K – 7585
2022
Q3 		$1K Sell
123
-397
-76% -$1.94K ﹤0.01% 6365
2022
Q2 		$2K Buy
+520
New +$2.25K ﹤0.01% 6331
2022
Q1 		– Sell
-12,423
Closed -$105K – 7408
2021
Q4 		$105K Buy
12,423
+12,370
+23,340% +$102K ﹤0.01% 5602
2021
Q3 		$0 Sell
53
-30,357
-100% -$274K ﹤0.01% 7222
2021
Q2 		$321K Sell
30,410
-32,287
-51% -$451K ﹤0.01% 4835
2021
Q1 		$1.01M Buy
62,697
+22,581
+56% +$595K ﹤0.01% 4245
2020
Q4 		$1.85M Sell
40,116
-23,931
-37% -$1.11M ﹤0.01% 3553
2020
Q3 		$2.25M Buy
64,047
+20,967
+49% +$631K ﹤0.01% 3214
2020
Q2 		$1.05M Buy
+43,080
New +$923K ﹤0.01% 3778

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wells Fargo's IMVT Position: Q2 2026 in Review

Wells Fargo increased its Immunovant (IMVT) stake by 341% in Q2 2026, buying an estimated $3.46M and bringing the position to 146,639 shares worth $5.65M. The position accounts for ﹤0.01% of the portfolio, ranked #2734.

Wells Fargo first reported a position in IMVT in Q2 2020 and has held it in 23 quarters since. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Wells Fargo held 146,639 shares of Immunovant worth $5.65M as of Q2 2026.
  • Wells Fargo bought 113,417 Immunovant shares in Q2 2026, an estimated $3.46M.
  • Immunovant made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #2734 holding.
  • Wells Fargo first reported a position in Immunovant in Q2 2020 and has held it in 23 quarters since.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.